StrokeViewer’s AI stroke portfolio
We offer you an advanced AI stroke portfolio built to empower physicians to make informed treatment decisions anywhere, anytime.
AI stroke portfolio
Advanced techniques, best results
Built with precision
Automated vessel tracing
Our AI is built to accurately reconstruct the vasculature and trace precisely along the blood vessels until any potential thrombus is detected.
This unique approach ensures fewer LVOs are missed.
Trained using the most heterogeneous data
Handles suboptimal
Handles suboptimal
scan quality
Trained on the renowned MR CLEAN and several other datasets that include patients across the world, so our AI can:
- process thicker slices;
- improve signal-to-noise-ratio;
- accept images from less advanced scanners;
- detect the phase of acquisition for quality assurance.
Non-black box approach
Highest sensitivity
Recent clinical studies show that our AI stroke algorithms’ high sensitivity and specificity give excellent accuracy, which is key to providing patients the treatment they deserve. Results are always visible, so any decisions are left to your own observation.
Choose AI Algorithms Trained on the Most Heterogenous Dataset
it’s about time
Detects subtle ICH & SAH hemorrhages
Hemorrhage detection
This AI stroke algorithm detects subtle bleeds and notifies your team immediately. Results are displayed via a binary contour mask and multicolored likelihood map for easy interpretation.
- Detection of subtle subarachnoid and intraparenchymal hemorrhages as well as other intracranial hemorrhages
- Sensitivity of 97% & Specificity of 96%*
- Auto-segmentation and volumetric measurements displayed through color-coded overlay
* Internal clinical validation study, 2023
Automating ASPECTS
ASPECTS
Output of a standardized ASPECT score in minutes. With automatic detection of hypodensity on NCCT scans, you can quickly interpret results and make the best treatment decision.
- Alignment of the brain for easier reading of the scan
- Automatic identification of the ASPECTS regions on NCCT
- Delivers results with high consistency and reliability*
* Internal clinical validation study, 2021
Reducing the number of undetected LVO’s
LVO triaging
You and your team are instantly notified of a suspected Large Vessel Occlusion (LVO). The notification takes you straight to the patient timeline, where you can enter and store key clinical information.
- Access to results via your mobile device, email or PACS to diagnose an LVO patient faster
- Occlusion detection (including distal M2 branch)
- Outstanding sensitivity for occlusion detection, Sensitivity of 99% including ICA-T and M1 occlusions in the anterior circulation*
* HALO FDA application 2020
Precisely locating the LVO
LVO location
Your team is notified of the precise location of a suspected occlusion immediately. The notification takes you directly to the scan, helping you save treatment time and reduce the risk of missing an LVO.
- LVO identifier to pinpoint LVO location
- You are navigated to the relevant slices containing the occlusion
- Non-black box approach, meaning results are always visible for your own interpretation
* HALO FDA application 2020
* Fasen et al 2022
Quantitative measurements of the collateral circulation
Collaterals
An automated collateral score is given to you as a percentage. Visualization of the vessels combined with thrombus location helps you determine whether the patient will benefit from endovascular therapy.
- Collateral status is the only proven treatment effect modifier currently in the clinical guidelines*
- You are informed of the acquisition phase for quality assurance
- The automated score is given as a quantitative collateral score and percentage of contralateral hemisphere, reducing interobserver variability
* A.M.M. Boers et al. AJNR 2018
* Internal clinical validation study, 2022
Automated quantification
Automated perfusion analysis
Quantifying the ischemic core and penumbra helps determine the amount of brain tissue that could be salvaged with endovascular treatment.
- Easy-to-interpret multicolored perfusion maps visible through our DICOM Viewer
- Core and mismatch volumes with DEFUSE-3 criteria to help determine eligibility for treatment
- Automated AIF, VOF and motion correction to standardize results